CECR2 (CECR2 histone acetyl-lysine reader)

symbol
CECR2
locus group
protein-coding gene
location
22q11.1-q11.21
gene_family
-
alias symbol
KIAA1740
alias name
None
entrez id
27443
ensembl gene id
ENSG00000099954
ucsc gene id
uc010gqv.2
refseq accession
NM_031413
hgnc_id
HGNC:1840
approved reserved
2000-01-31
22q11.1-q11.21
ChineseEnglish

CECR2, located on human chromosome 22, encodes a critical subunit of the BAF (BRG1/BRM-associated factor) chromatin remodeling complex, a multi-protein assembly that utilizes ATP-dependent hydrolysis to reposition nucleosomes and modulate chromatin accessibility. As a core component of this family, CECR2 facilitates the dynamic regulation of gene transcription by altering the physical structure of chromatin, thereby playing an indispensable role in embryonic development, cellular differentiation, and the maintenance of neural system function. Its activity is particularly vital during the organogenesis of the heart, brain, and eyes, where precise spatiotemporal control of gene expression is required to establish proper tissue architecture and cellular identity. The functional integrity of CECR2 relies on its stable interaction with other BAF complex members; consequently, loss-of-function mutations or dysregulated expression can disrupt the complex’s overall remodeling capacity, leading to profound developmental consequences. Clinically, pathogenic variants in CECR2 are associated with Cat Eye Syndrome, a rare congenital disorder characterized by colobomas of the iris, anal atresia, and cardiac defects, reflecting the gene’s critical role in early embryonic patterning. Furthermore, aberrant CECR2 expression has been implicated in oncogenesis, particularly in neuroblastoma and leukemia, where overexpression may disturb the balance of chromatin remodeling, resulting in uncontrolled cell proliferation, while underexpression can impair normal neurocardiac development and contribute to congenital malformations. Thus, CECR2 serves as a key regulator of cell fate decisions and tissue-specific functions, linking epigenetic regulation to both normal developmental processes and disease pathogenesis.

Nucleotide sequence of CECR2:[NCBI]
Loading Gene Browser...
Protein Sequence
1MCPEEGGAAG LGELRSWWEV PAIAHFCSLF RTAFRLPDFE
41IEELEAALHR DDVEFISDLI ACLLQGCYQR RDITPQTFHS
81 YLEDIINYR WELEEGKPNP LREASFQDLP LRTRVEILHR
121LCDYRLDADD VFDLLKGLDA DSLRVEPLGE DNSGALYWYF
161Y GTRMYKED PVQGKSNGEL SLSRESEGQK NVSSIPGKTG
201KRRGRPPKRK KLQEEILLSE KQEENSLASE PQTRHGSQGP
241GQ GTWWLLC QTEEEWRQVT ESFRERTSLR ERQLYKLLSE
281DFLPEICNMI AQKGKRPQRT KAELHPRWMS DHLSIKPVKQ
321EET PVLTRI EKQKRKEEEE ERQILLAVQK KEQEQMLKEE
361RKRELEEKVK AVEGMCSVRV VWRGACLSTS RPVDRAKRRK
401LREE RAWLL AQGKELPPEL SHLDPNSPMR EEKKTKDLFE
441LDDDFTAMYK VLDVVKAHKD SWPFLEPVDE SYAPNYYQII
481KAPMD ISSM EKKLNGGLYC TKEEFVNDMK TMFRNCRKYN
521GESSEYTKMS DNLERCFHRA MMKHFPGEDG DTDEEFWIRE
561DEKREK RRS RAGRSGGSHV WTRSRDPEGS SRKQQPMENG
601GKSLPPTRRA PSSGDDQSSS STQPPREVGT SNGRGFSHPL
641HCGGTPS QA PFLNQMRPAV PGTFGPLRGS DPATLYGSSG
681VPEPHPGEPV QQRQPFTMQP PVGINSLRGP RLGTPEEKQM
721CGGLTHLS N MGPHPGSLQL GQISGPSQDG SMYAPAQFQP
761GFIPPRHGGA PARPPDFPES SEIPPSHMYR SYKYLNRVHS
801AVWNGNHGA TNQGPLGPDE KPHLGPGPSH QPRTLGHVMD
841SRVMRPPVPP NQWTEQSGFL PHGVPSSGYM RPPCKSAGHR
881LQPPPVPAPS SLFGAPAQA LRGVQGGDSM MDSPEMIAMQ
921QLSSRVCPPG VPYHPHQPAH PRLPGPFPQV AHPMSVTVSA
961PKPALGNPGR A PENSEAQE PENDQAEPLP GLEEKPPGVG
1001TSEGVYLTQL PHPTPPLQTD CTRQSSPQER ETVGPELKSS
1041SSESADNCKA MK GKNPWPS DSSYPGPAAQ GCVRDLSTVA
1081DRGALSENGV IGEASPCGSE GKGLGSSGSE KLLCPRGRTL
1121QETMPCTGQN AAT PPSTDP GLTGGTVSQF PPLYMPGLEY
1161PNSAAHYHIS PGLQGVGPVM GGKSPASHPQ HFPPRGFQSN
1201HPHSGGFPRY RPPQ GMRYS YHPPPQPSYH HYQRTPYYAC
1241PQSFSDWQRP LHPQGSPSGP PASQPPPPRS LFSDKNAMAS
1281LQGCETLNAA LTSPT RMDA VAAKVPNDGQ NPGPEEEKLD
1321ESMERPESPK EFLDLDNHNA ATKRQSSLSA SEYLYGTPPP
1361LSSGMGFGSS AFPPHS VML QTGPPYTPQR PASHFQPRAY
1401SSPVAALPPH HPGATQPNGL SQEGPIYRCQ EEGLGHFQAV
1441MMEQIGTRSG IRGPFQE MY RPSGMQMHPV QSQASFPKTP
1481TAATSQEEVP PHKPPTLPLD QS
Structure predicted by AlphaFold DB(UniProt: Q9BXF3). Color indicates pLDDT confidence (dark blue = high, yellow/orange = low).
SNP variants of CECR2:           Showing partial SNPs
rs78914       rs113837       rs174287       rs174288       rs174289       rs174290       rs174291       rs174293       rs174294       rs174295       rs174296       rs174297       rs174298       rs174299       rs174300       rs174301       rs174302      

Tissue expression of CECR2:    [UniProt]

Gene expression across tissues
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
ACGAAGAGATATCACGCCTC
59
CTTCCCTTCTTCGAGCTCC
59
CTGTGATGATGGAACAAATTGG
58
GAGAATCGCTTGAACCCTG
58
GCTATGTATAAAGTTCTAGACGTGG
59
GGCATAAGATTCATCCACAGG
58
GTGATGATGGAACAAATTGGC
58
CATCTGCATTCCTGATGGTC
58
GATGACGTGGAGTTTATCAGTG
59
TGTCTGAGGCGTGATATCTC
59
GTGATGATGGAACAAATTGGC
58
GAGAATCGCTTGAACCCTG
58
GATGATGGAACAAATTGGCAC
58
GAGAATCGCTTGAACCCTG
58
AGATGACGTGGAGTTTATCAG
57
GTCTGAGGCGTGATATCTC
57
GTGATGATGGAACAAATTGGC
58
CATCTGCATTCCTGATGGT
57

Subcellular localization of CECR2 (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for CECR2:

GO ID
Protein
Source DB
GO:0021915
A0A087WT21 (UniProtKB)
IEA
GO:0043044
A0A087WT21 (UniProtKB)
IEA
GO:0090537
A0A087WT21 (UniProtKB)
IEA
GO:0021915
A0A0R4J2E1 (UniProtKB)
IEA
GO:0043044
A0A0R4J2E1 (UniProtKB)
IEA
GO:0090537
A0A0R4J2E1 (UniProtKB)
IEA
GO:0001842
B7WPH3 (UniProtKB)
IEA
GO:0001843
B7WPH3 (UniProtKB)
IEA
GO:0005719
B7WPH3 (UniProtKB)
IEA
GO:0007338
B7WPH3 (UniProtKB)
IEA
GO:0043044
B7WPH3 (UniProtKB)
IEA
GO:0060122
B7WPH3 (UniProtKB)
IEA
GO:0090102
B7WPH3 (UniProtKB)
IEA
GO:0090537
B7WPH3 (UniProtKB)
IEA
GO:0000910
Q9BXF3 (UniProtKB)
NAS
GO:0005515
Q9BXF3 (UniProtKB)
IPI
GO:0005515
Q9BXF3 (UniProtKB)
IPI
GO:0005515
Q9BXF3 (UniProtKB)
IPI
GO:0005634
Q9BXF3 (UniProtKB)
IDA
GO:0006309
Q9BXF3 (UniProtKB)
TAS
GO:0007010
Q9BXF3 (UniProtKB)
NAS
GO:0016192
Q9BXF3 (UniProtKB)
NAS
GO:0021915
Q9BXF3 (UniProtKB)
IEA
GO:0043044
Q9BXF3 (UniProtKB)
IDA
GO:0090537
Q9BXF3 (UniProtKB)
IDA
GO:0097194
Q9BXF3 (UniProtKB)
IDA

microRNAs potentially regulating CECR2:     

String
BioGrid
mentha
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
Neural Tube Defects 0.12 1 0 CTD_human
Anencephaly 0.08 0 0 MGD
Tobacco Use Disorder 0.002367032 1 0 GAD
Exencephaly 0.000814326 3 0 BeFree
eyelids (symptom) 0.000271442 1 0 BeFree
DiGeorge Syndrome 0.000271442 1 0 BeFree
Shprintzen syndrome 0.000271442 1 0 BeFree
Cat eye syndrome 0.000271442 1 0 BeFree
NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells.
Sneddon MS, Tsou CJ, Fu X, Shelat AA, Pomerantz WCK Bioconjug Chem IF: 4.5 2026-03-18
Mechanistic insights into acetylated histone recognition by the CECR2 bromodomain.
Chakraborty S, Roy A, Prusty S, Sahoo S, Sudhamalla B Biochem J IF: 3.9 2026-08-05
Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis.
Zhu H, Kanda M, Shimizu D, Sato Y, Bayasgalan T, Hamrah MH, Martinez FEG, Shinozuka T, Aoki K, Umeda S, Takami H, Hattori N, Hayashi M, Tanaka C, Nakayama G, Kodera Y Clin Transl Oncol IF: 2.7 2026-02-00
Heterozygous CECR2 variants support a distinct neurodevelopmental syndrome with features overlapping cat eye syndrome.
Acharya A, Järvelä I, Hernandez A, Rajendran Y, Bharadwaj T, Goodloe DH, Hiatt SM, Morrison J, Wheeler PG, Hunter JM, Supinger R, Hickey SE, Petersen AK, Magnussen K, Scala M, Striano P, Zara F, Leppälä J, Leal SM, Schrauwen I HGG Adv IF: 3.1 2026-07-09
Synergistic ligand anchoring and electronic modulation in CeMIL-101-NH₂ boosting ultrasmall Niδ+ sites for efficient catalytic hydrogenation.
Chen J, Wang L, Huang X, Wang J, Meng H, Gao H, Chen X, Wang G J Colloid Interface Sci IF: 9.6 2026-04-00
Identifying a non-conserved site for achieving allosteric covalent inhibition of CECR2.
Tang CL, Li YQ, Du XK, Fang XX, Guang YM, Li PZ, Chen S, Xue SY, Yu JM, Liu XY, Luo YP, Zhou LX, Luo C, Xiong H, Liang ZJ, Ding H Acta Pharmacol Sin IF: 10.4 2025-05-00
The interaction of HT-2 toxin and Akt1 on gene expression regulation in Kashin-Beck disease pathogenesis.
Liao X, Yang X, Jia X, Zhang Q, Naren G, Zhang J, Niu H, Wei H, Wu C Toxicon IF: 2.8 2025-09-00
Cat Eye Syndrome Chromosome Region Candidate 2 (CECR2) in chromatin remodeling and cancer: A review.
Ali M, Rafiq A, Rakhshan R, Beigh MA Int J Biol Macromol IF: 8.7 2025-11-00

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]